Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea
· Delayed Price · Currency is KRW 1,814.00
-77.00 (-4.07%)
Mar 9, 2026, 3:30 PM KST
Yungjin Pharm. Revenue
Yungjin Pharm. had revenue of 38.98B KRW in the quarter ending September 30, 2013, with 4.67% growth. This brings the company's revenue in the last twelve months to 158.79B, up 23.36% year-over-year. In the year 2012, Yungjin Pharm. had annual revenue of 137.69B with 22.82% growth.
Revenue (ttm)
158.79B
Revenue Growth
+23.36%
P/S Ratio
2.09
Revenue / Employee
276.63M
Employees
574
Market Cap
331.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2012 | 137.69B | 25.58B | 22.82% |
| Dec 31, 2011 | 112.11B | -4.21B | -3.62% |
| Dec 31, 2010 | 116.32B | 12.94B | 12.52% |
| Dec 31, 2009 | 103.38B | -7.53B | -6.79% |
| Dec 31, 2008 | 110.91B | 1.25B | 1.14% |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
| Dec 31, 2004 | Pro | Pro | Pro |
| Dec 31, 1999 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humedix | 110.99B |
| Huons | 602.21B |
| Korea United Pharm | 161.44B |
| BNC Korea | 98.11B |
| Hyundai Pharmaceutical | 108.14B |
| JW Holdings | 935.51B |
| CMG Pharmaceutical | 100.41B |
| FutureChem Co.,Ltd | 18.75B |